4.4 Article

Can We Declare Victory and Move On? The Case Against Funding Burden-of-Disease Studies

Journal

PHARMACOECONOMICS
Volume 32, Issue 12, Pages 1153-1155

Publisher

ADIS INT LTD
DOI: 10.1007/s40273-014-0200-8

Keywords

-

Ask authors/readers for more resources

Resources devoted to the development of burden-of-disease studies detract from much needed cost-effectiveness and cost-benefit studies. Practitioners need to help funders of burden-of-disease projects recognize the potential of all tools of decision analysis and economic evaluation in improving the efficiency and equity for the health care system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available